Medicare Enrolled
Dr. Ryan Dickert, MD
Family Medicine · Crystal River, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Dickert from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dickert? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dickert
Dr. Ryan Dickert is a family medicine in Crystal River, FL, with 11 years in practice. Based on federal Medicare data, Dr. Dickert performed 59,002 Medicare services across 33,175 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dickert received a total of $2,312 from 22 pharmaceutical and/or device companies across 156 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dickert is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice▲ Top 0% volume in FL$ $2,312 industry payments
Medicare Practice Summary
Medicare Utilization ↗59,002
Medicare services
Top 0% in FL for family medicine
33,175
Unique beneficiaries
$19
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,364 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,883 | $87 | $140 |
| Blood draw (venipuncture) | 2,811 | $8 | $10 |
| Complete blood count (CBC) with differential | 2,351 | $8 | $25 |
| Blood potassium level | 2,307 | $5 | $9 |
| Blood sodium level | 2,271 | $5 | $10 |
| Blood creatinine level | 2,260 | $5 | $10 |
| Blood chloride level | 2,242 | $5 | $7 |
| Blood glucose (sugar) level | 2,240 | $4 | $8 |
| Urea nitrogen level to assess kidney function, quantitative | 2,240 | $4 | $10 |
| Liver enzyme (sgpt), level | 2,153 | $5 | $10 |
| Liver enzyme (sgot), level | 2,149 | $5 | $10 |
| Bilirubin level, total | 2,131 | $5 | $9 |
| Calcium level, total | 2,126 | $5 | $10 |
| Phosphatase (enzyme) level, alkaline | 2,121 | $5 | $9 |
| Total protein level, blood | 2,088 | $4 | $8 |
| Lipid panel (cholesterol and triglycerides) | 1,779 | $13 | $29 |
| Thyroid stimulating hormone (TSH) test | 1,748 | $16 | $45 |
| Thyroid hormone, t3 measurement, free | 1,734 | $17 | $35 |
| Thyroxine (thyroid chemical), total | 1,674 | $7 | $20 |
| Vitamin B-12 level test | 1,406 | $15 | $33 |
| Folic acid level test | 1,362 | $14 | $32 |
| Homocysteine (amino acid) level | 1,280 | $18 | $35 |
| Apolipoprotein level | 1,265 | $21 | $34 |
| Advance care planning consultation, first 30 min | 884 | $80 | $110 |
| Hemoglobin A1c test (diabetes monitoring) | 877 | $10 | $22 |
| Annual wellness visit, follow-up | 851 | $126 | $135 |
| Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 716 | $26 | $30 |
| Annual depression screening | 619 | $18 | $20 |
| Office visit, established patient (20-29 min) | 445 | $65 | $100 |
| Automated urinalysis | 389 | $2 | $5 |
| Vitamin D level test | 387 | $29 | $60 |
| Glycated protein level | 304 | $16 | $31 |
| Dexamethasone injection (steroid) | 304 | $0 | $2 |
| Infectious disease DNA/RNA test | 278 | $34 | $50 |
| Urine microalbumin (protein) analysis | 276 | $6 | $10 |
| Creatinine test (kidney function) | 275 | $5 | $10 |
| Chest X-ray, 2 views | 274 | $24 | $60 |
| Ferritin level test (iron stores) | 263 | $13 | $30 |
| Iron level test | 261 | $6 | $15 |
| Transferrin (iron binding protein) level | 259 | $12 | $25 |
| Parathyroid hormone level test | 237 | $40 | $80 |
| Ultrasound of both sides of head and neck blood flow | 237 | $139 | $350 |
| Magnesium level test | 235 | $7 | $15 |
| Prostate cancer screening; prostate specific antigen test (psa) | 225 | $19 | $50 |
| Telephone medical discussion with physician, 11-20 minutes | 209 | $61 | $100 |
| Albumin (protein) level | 202 | $5 | $9 |
| Phosphate level test | 202 | $5 | $20 |
| Electrocardiogram (EKG), 12-lead | 192 | $10 | $40 |
| Telephone medical discussion with physician, 5-10 minutes | 191 | $38 | $50 |
| New patient office visit (45-59 min) | 169 | $94 | $215 |
| Echocardiogram, transthoracic | 153 | $139 | $350 |
| Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique | 138 | $34 | $50 |
| Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique | 138 | $34 | $50 |
| Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 136 | $140 | $150 |
| Uric acid level test | 125 | $4 | $8 |
| Prothrombin time test (blood clotting) | 122 | $4 | $12 |
| PSA test (prostate cancer screening) | 119 | $18 | $50 |
| Drug injection, under skin or into muscle | 115 | $10 | $30 |
| Annual alcohol misuse screening, 5 to 15 minutes | 113 | $18 | $20 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 101 | $18 | $32 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 83 | $15 | $25 |
| Transitional care management services for problem of high complexity | 74 | $212 | $311 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 71 | $25 | $30 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 68 | $1 | $15 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 64 | $124 | $300 |
| Ultrasound scan of abdominal aorta | 61 | $102 | $115 |
| Free thyroxine (T4) test | 59 | $9 | $18 |
| Injection, methylprednisolone acetate, 80 mg | 56 | $8 | $25 |
| Removal of impacted ear wax | 55 | $31 | $65 |
| Complete ultrasound scan behind abdominal cavity | 55 | $81 | $190 |
| Complete ultrasound scan of abdomen | 54 | $82 | $215 |
| Testosterone (hormone) level, total | 51 | $25 | $60 |
| Office visit, established patient, complex (40-54 min) | 41 | $137 | $190 |
| Transitional care management services for problem of at least moderate complexity | 41 | $153 | $220 |
| Glutamyltransferase (liver enzyme) level | 39 | $7 | $12 |
| Complete ultrasound of abdomen and pelvis artery and vein blood flow | 37 | $193 | $350 |
| X-ray of knee, 1-2 views | 35 | $22 | $55 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 35 | $139 | $275 |
| Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | 34 | $190 | $300 |
| X-ray of lower and sacral spine, 2-3 views | 29 | $29 | $70 |
| Joint injection, major joint | 28 | $48 | $120 |
| Prolactin (milk producing hormone) level | 28 | $19 | $32 |
| Ultrasound of leg arteries or artery grafts | 28 | $171 | $350 |
| Shoulder X-ray, 2+ views | 26 | $24 | $60 |
| Hip X-ray, 2-3 views | 26 | $29 | $60 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 26 | $52 | $165 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 25 | $91 | $175 |
| Foot X-ray, 3+ views | 20 | $25 | $45 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 19 | $162 | $175 |
| Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | 16 | $8 | $40 |
| X-ray of upper spine, 6 or more views | 15 | $44 | $140 |
| Ultrasound scan of head and neck soft tissue | 14 | $85 | $165 |
| Destruction of precancerous skin growth, 1 | 13 | $42 | $105 |
| Skin biopsy, tangential | 12 | $78 | $120 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $72 | $140 |
| Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 11 | $28 | $35 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
1.9% medium
97.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,312
Total received (2018-2024)
Avg $330/year across 7 years
Top 21% in FL for family medicine
22
Companies
156
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,312 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$122
2023$70
2022$168
2021$304
2020$423
2019$759
2018$465
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$500
AstraZeneca Pharmaceuticals LP
$362
Boehringer Ingelheim Pharmaceuticals, Inc.
$318
Novo Nordisk Inc
$195
Janssen Pharmaceuticals, Inc
$168
GlaxoSmithKline, LLC.
$137
Lilly USA, LLC
$131
PFIZER INC.
$118
Amarin Pharma Inc.
$58
SANOFI-AVENTIS U.S. LLC
$56
Merck Sharp & Dohme Corporation
$55
Novartis Pharmaceuticals Corporation
$45
AbbVie Inc.
$29
Astellas Pharma US Inc
$21
Nalpropion Pharmaceuticals LLC
$19
Echosens North America, Inc.
$18
Endogastric Solutions, Inc
$17
ARBOR PHARMACEUTICALS, INC.
$17
Circassia Pharmaceuticals Inc
$13
Roche Diagnostics Corporation
$12
Eisai Inc.
$12
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$12
Top 3 companies account for 51.0% of total payments
Associated products mentioned in payments ›
ANORO · ANORO ELLIPTA · Aimovig · BYDUREON · CD cobas Analyzer Series · CHANTIX · CONTRAVE · DUAKLIR PRESSAIR · Dayvigo · ELIQUIS · ENTRESTO · ESOPHYX · EVENITY · Edarbyclor · FARXIGA · FibroScan · JANUVIA · JARDIANCE · LINZESS · MOUNJARO · Otezla · Ozempic · PREVNAR 13 · Prolia · Repatha · SHINGRIX · SOLIQUA 100/33 · SPRAVATO · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · Vascepa · Veozah · Victoza · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $4 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
82
Per 100K population
51.7
County median income
$55,355
Nearest hospital
TAMPA GENERAL HOSPITAL CRYSTAL RIVER
6.6 mi
6.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Dickert is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Dickert experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Dickert performed 2,883 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dickert receive payments from pharmaceutical companies?
Yes. Dr. Dickert received a total of $2,312 from 22 companies across 156 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dickert's costs compare to other family medicines in Crystal River?
Dr. Dickert's average Medicare payment per service is $19. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dickert) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Crystal River
Browse family medicines in Crystal River ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in FL
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in FL
Which FL family medicines receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology